exscientia's Automated Invention is a state-of-the-art, proprietary computational design technology that represents a completely new way to invent and optimise new medicines. Molecules can be designed against multi-target profiles in order to enhance efficacy, safety and development efficiency. exscientia is the pioneer in exploiting the explosion in biomedical data to the design of new molecules.

encoding creativity

exscientia's Automated Invention technology mimics the creative drug design process by the evolutionary optimisation of compounds to a target product profile.

enhancing productivity

exscientia's Automated Invention is the first technology validated to design to multi-target profiles to achieve exquisite selectivity or designer polypharmacology.

extending possibility

exscientia's mission is to design differentiated medicines in a highly productive and scalable manner.